Skip to content

Clinical trials

Phase 1 Hypoglycemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoglycemia Phase: Phase 1 Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20071
20084
20094
20101
20135
20141
20153
20161
20172
20181
20191
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting6
Terminated3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Maryland, Baltimore4
Baylor Research Institute3
The University of Texas Health Science Center at San Antonio3
Yale University3
University of Pennsylvania2
Areeg El-Gharbawy1
AstraZeneca1
Bayhill Therapeutics1
Cook Children's Health Care System1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoglycemia30
Diabetes Mellitus, Type 111
Diabetes Mellitus5
Hyperglycemia5
Diabetes Mellitus, Type 23
Insulin Resistance3
Autoimmune Diseases1
Brain Neoplasms1
Burns1
Congenital Hyperinsulinism1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.